Ovid Therapeutics: LifeSci Capital initiates coverage on Outperform, PT $4.

lunes, 22 de diciembre de 2025, 10:35 am ET1 min de lectura
OVID--

Ovid Therapeutics: LifeSci Capital initiates coverage on Outperform, PT $4.

Ovid Therapeutics: LifeSci Capital initiates coverage on Outperform, PT $4.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios